Your browser doesn't support javascript.
loading
[Role of allergen immunotherapy in the prevention of allergic asthma].
Liang, H L; Gao, Y D.
Afiliação
  • Liang HL; Department of Allergy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Gao YD; Department of Allergy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China Department of Allergy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(9): 1309-1315, 2023 Sep 06.
Article em Zh | MEDLINE | ID: mdl-37743289
The prevalence of allergic asthma is still increasing, which affects the quality of life of patients, threatens their lives, and brings enormous social and economic burden. Allergen immunotherapy (AIT) is the only treatment that can alter the progression of the "Atopic March". It has been widely used in the treatment of allergic rhinitis and conjunctivitis, and its role and effect in the treatment of allergic asthma have been gradually recognized. A few studies have shown that AIT may have a preventive effect on the development and progression of allergic asthma. In this article, the definition of tertiary prevention of allergic asthma is described, and the respective role of AIT in primary, secondary and tertiary prevention of allergic asthma is summarized and analyzed. The aim of this article is to provide evidence for the prevention and control of allergic asthma.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Rinite Alérgica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Rinite Alérgica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China